Skip to main content
logo
Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
4,459.00
+49.00 (1.11%)
At close: Dec 8, 2025

TYO:4502 Revenue

Takeda Pharmaceutical Company had revenue of 1.11T JPY in the quarter ending September 30, 2025, a decrease of -5.38%. This brings the company's revenue in the last twelve months to 4.42T, down -2.84% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.

Revenue (ttm)
4.42T
Revenue Growth
-2.84%
P/S Ratio
1.59
Revenue / Employee
93.08M
Employees
47,455
Market Cap
7.04T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20254.58T317.79B7.45%
Mar 31, 20244.26T236.28B5.87%
Mar 31, 20234.03T458.47B12.85%
Mar 31, 20223.57T371.19B11.61%
Mar 31, 20213.20T-93.38B-2.84%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Otsuka Holdings2.42T
Astellas Pharma2.01T
Daiichi Sankyo Company1.98T
Chugai Pharmaceutical1.21T
Terumo1.06T
Olympus977.65B
HOYA Corporation892.50B
Eisai804.39B
Revenue Rankings

Takeda Pharmaceutical Company News

More News